Meibomian Gland Dysfunction: The Hidden Cause of Dry Eye
Understanding Meibomian Gland Dysfunction
Meibomian gland dysfunction (MGD) is one of the most common yet frequently overlooked causes of dry eye disease. According to the TFOS DEWS II report, meibomian gland dysfunction is present in the majority of dry eye cases, making it the leading cause of evaporative dry eye (TFOS DEWS II, 2017). These tiny oil-producing glands line the edges of your eyelids and play a critical role in keeping your tears stable and your eyes comfortable. At Greenwich Ophthalmology Associates, our dry eye specialists help patients throughout the greater NY/CT region identify and treat MGD using targeted diagnostic tools and personalized therapies. Because dry eye disease can present differently from person to person, a thorough evaluation of the tear film, ocular surface, and meibomian glands helps ensure that treatment targets the specific underlying cause rather than masking symptoms temporarily.
Your eyelids contain approximately 25 to 40 meibomian glands in the upper lid and 20 to 30 in the lower lid. These glands produce meibum, a specialized oil that forms the outermost layer of your tear film. This lipid layer prevents tears from evaporating too quickly and keeps the surface of your eye smooth and lubricated between blinks. Understanding the root cause of your symptoms is a critical first step, because the most effective treatment for dry eye depends on whether the condition involves insufficient tear production, excessive tear evaporation, or a combination of both mechanisms.
What Is Meibomian Gland Dysfunction
MGD occurs when the meibomian glands in your upper and lower eyelids fail to produce or secrete adequate oils for your tear film. In MGD, the gland openings along the lid margin become blocked with thickened, waxy secretions. Without fresh oil reaching the tear film, tears evaporate rapidly, leaving the eye surface exposed and irritated. Many patients find that dry eye symptoms fluctuate with environmental factors such as humidity levels, screen time, air conditioning, and seasonal allergens, which is why ongoing monitoring and periodic reassessment of your treatment plan can help maintain lasting comfort.
MGD can present in different ways. Obstructive MGD, the most common form, occurs when the gland openings become blocked. Hyposecretory MGD involves reduced oil production even without obvious blockage. Some patients have a combination of both forms. Our practice serves patients throughout the greater New York and Connecticut region, and we understand that living with chronic eye discomfort can affect your ability to work, read, drive, and enjoy everyday activities, which is why we take a comprehensive and individualized approach to care.
Left untreated, chronic MGD can cause permanent changes to the meibomian glands. Over time, blocked glands may atrophy and lose their ability to produce oil altogether. Early detection and treatment help preserve gland function and prevent irreversible damage. Identifying contributing factors such as medications, systemic health conditions, hormonal changes, and environmental exposures is an important part of the evaluation process, because addressing these influences alongside direct ocular surface treatment often leads to more sustained improvement.
Causes and Risk Factors
MGD becomes more common with age as meibomian gland function naturally declines. Hormonal changes, particularly during menopause, can affect gland secretion. Women are affected more often than men. Each patient receives a customized management plan that may evolve over time as symptoms improve or new contributing factors emerge, ensuring that the approach remains aligned with your current needs and goals.
Conditions like blepharitis often coexist with MGD. Bacterial overgrowth on the eyelids can contribute to gland inflammation and blockage. Demodex mites can also infiltrate and obstruct the glands. The relationship between eyelid health and tear film stability is well established in the clinical literature, and addressing lid margin disease is often a necessary foundation for effective dry eye treatment.
Extended screen time reduces blink rate, limiting the natural expression of oil from the glands. Contact lens wear, certain medications, and environmental factors like low humidity can also contribute to MGD development. Regular follow-up visits allow our team to monitor your progress, evaluate how your ocular surface is responding to treatment, and make adjustments to your care plan as needed to help you achieve the best possible long-term outcome.
Symptoms of MGD
Patients with MGD often experience burning, stinging, or a gritty sensation in their eyes. Symptoms typically worsen throughout the day and may be most noticeable after prolonged reading or computer use. Fluctuating vision that temporarily clears with blinking is another common complaint. Dry eye disease is a chronic condition for many patients, and effective long-term management often involves a combination of in-office treatments, prescription therapies, and daily at-home care habits that work together to maintain tear film health and ocular surface comfort.
During examination, your dry eye specialist may observe thickened or cloudy oil at the gland openings, reduced number of expressible glands, eyelid margin redness or irregularity, and a shortened tear break-up time indicating rapid tear evaporation. We encourage patients to communicate openly about how their symptoms are affecting their daily routine, because details about when discomfort is worst, which activities trigger it, and how it has changed over time help guide treatment decisions and ensure we are addressing the issues that matter most to you.
Diagnosis of MGD
Diagnosing MGD requires more than a standard eye exam. A comprehensive dry eye evaluation includes assessment of eyelid margin appearance, evaluation of gland expressibility and meibum quality, and meibography imaging to visualize gland structure. Advanced diagnostic technology plays an important role in dry eye care by providing objective measurements of tear film quality, meibomian gland health, and ocular surface integrity that go beyond what can be observed during a standard eye examination.
Meibography uses infrared imaging to photograph the meibomian glands through the eyelid. This allows your doctor to see the number, size, and shape of your glands and identify any areas of gland loss or atrophy. This information guides treatment decisions and allows tracking of gland health over time. For patients who have tried over-the-counter remedies without adequate relief, a comprehensive dry eye evaluation can reveal the specific type and severity of the condition and open the door to targeted treatments that address the underlying problem rather than temporarily soothing symptoms.
Treatment Options
Warm compresses applied daily help soften hardened meibum and improve oil flow. Gentle lid massage following warm compresses helps express blocked glands. Lid hygiene with dedicated cleansers reduces bacterial load along the lid margin. Maintaining a healthy ocular surface is important not only for comfort but also for visual clarity, because an unstable tear film can cause fluctuating vision, glare sensitivity, and difficulty with tasks that require sustained focus such as reading, driving, and working on a computer.
For moderate to severe MGD, in-office treatments provide more intensive intervention. LipiFlow thermal pulsation combines controlled heat with pressure to clear blocked glands. BlephEx exfoliation removes debris and biofilm from the lid margins. These treatments can restore gland function more effectively than home therapies alone. Our dry eye specialists stay current with advances in diagnosis and treatment so that we can offer patients access to the most effective and evidence-based options available for managing their condition.
MGD is a chronic condition that requires ongoing management. Continuing at-home warm compresses and lid hygiene helps maintain the benefits of in-office treatments. Lipid-based artificial tears can supplement the oil layer between treatments. The ocular surface is a dynamic system influenced by tear production, tear drainage, eyelid function, blinking patterns, and environmental conditions, and effective dry eye management requires an approach that considers all of these factors rather than focusing on any single element in isolation.
Frequently Asked Questions
MGD is a chronic condition that can be effectively managed but not permanently cured. With consistent treatment, most patients achieve significant symptom relief and can prevent further gland loss.
For most MGD patients, daily warm compresses for 10 minutes followed by gentle lid massage is recommended. During flare-ups, twice daily treatment may be helpful.
Glands that are blocked but still structurally intact can often recover function with treatment. However, glands that have atrophied cannot regenerate, which is why early treatment is important.
MGD and blepharitis are related but distinct conditions. Blepharitis is inflammation of the eyelid margins, while MGD specifically involves dysfunction of the meibomian glands. The two conditions frequently occur together.
A comprehensive dry eye evaluation with meibography imaging can determine whether MGD is contributing to your symptoms. Symptoms alone cannot reliably distinguish MGD from other types of dry eye.
Get Treatment for MGD
Our dry eye specialists at Greenwich Ophthalmology Associates use advanced diagnostic tools to identify MGD and develop personalized treatment plans. Contact our office to schedule your comprehensive evaluation.
What our Patients say
4.8
Reviews
(3547)